NIT-Rourkela researchers patent skin cancer drug using pumpkin petals and silk proteins
Researchers at NIT-Rourkela have secured a patent for a novel skin cancer treatment. The drug formulation utilizes silver nanoparticles from pumpkin petals and sericin, a silk production byproduct, delivered via a chitosan capsule derived from shellfish. This eco-friendly ointment, composed of non-toxic materials, allows patients to directly apply the medication for effective transdermal delivery.
Researchers at NIT-Rourkela have secured a patent for a novel skin cancer treatment. The drug formulation utilizes silver nanoparticles from pumpkin petals and sericin, a silk production byproduct, delivered via a chitosan capsule derived from shellfish. This eco-friendly ointment, composed of non-toxic materials, allows patients to directly apply the medication for effective transdermal delivery.
